Welcome!
Tianjin Zhongxin Pharmaceutical Group Corporation
Results
Tianjin Zhongxin Pharma's 1Q earnings rise 30% to $36.3 mil on higher margins
SINGAPORE (Apr 27): Tianjin Zhongxin Pharmaceutical Group announced earnings of RMB173.4 million ($36.3 million) for the first quarter ended March, up 30% from its 1Q17 earnings of $133.8 million a year ago on improved gross profit margins.
April 27, 2018
Broker's Calls
Tianjin Zhongxin Pharma on its way to a stellar 2018 & beyond, says UOB
SINGAPORE (Apr 2): UOB Kay Hian is keeping Tianjin Zhongxin Pharmaceutical Group at “buy” with a higher target price of US$1.66 ($2.17), pegged to peer average of 14.1 times FY18 earnings.
April 02, 2018